Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Diabetic Retinopathy”

41 trials

Showing 20 of 41 results

Not applicableUnknownNCT01790945
What this trial is testing

Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography

Who this might be right for
Mild Nonproliferative Diabetic RetinopathyModerate Nonproliferative Diabetic RetinopathySevere Nonproliferative Diabetic Retinopathy+2 more
Retina Institute of Hawaii 500
Testing effectiveness (Phase 2)UnknownNCT04782128
What this trial is testing

Evaluation of RC28-E Injection in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
RemeGen Co., Ltd. 120
Not applicableEnded earlyNCT03242031
What this trial is testing

Medico-economic Comparison Between Treatment with Panretinal Photocoagulation by Laser in 1 Session Versus 4 Sessions in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Centre Hospitalier Universitaire Dijon 48
Not applicableStudy completedNCT01041690
What this trial is testing

Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease

Who this might be right for
Proliferative Diabetic Retinopathy
Cairo University 19
Large-scale testing (Phase 3)Study completedNCT02718326
What this trial is testing

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
Regeneron Pharmaceuticals 402
Not applicableUnknownNCT03863535
What this trial is testing

PRP vs PRP+IVC for Severe nPDR

Who this might be right for
Severe Nonproliferative Diabetic RetinopathyDiabetic RetinopathyDiabete Mellitus
Ruijin Hospital 40
Large-scale testing (Phase 3)Ended earlyNCT00600262
What this trial is testing

Intravitreal Bevacizumab for Diabetic Retinopathy

Who this might be right for
Severe NonproliferativeProliferative Diabetic RetinopathyActive Photocoagulated Diabetic Retinopathy
Asociación para Evitar la Ceguera en México
Large-scale testing (Phase 3)Study completedNCT00198497
What this trial is testing

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

Who this might be right for
Vitreous HemorrhageDiabetic Retinopathy
Bausch & Lomb Incorporated 510
Post-approval studies (Phase 4)Active Not RecruitingNCT06305143
What this trial is testing

Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Macular Edema
Shanghai Eye Disease Prevention and Treatment Center 58
Testing effectiveness (Phase 2)Study completedNCT04722991
What this trial is testing

Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

Who this might be right for
Diabetic Retinopathy
Bayer 109
Not applicableStudy completedNCT01270542
What this trial is testing

Avastin for PDR (Proliferative Diabetic Retinopathy)

Who this might be right for
Retinal DetachmentDiabetic Retinopathy
University of Southern California 20
Testing effectiveness (Phase 2)Looking for participantsNCT06321302
What this trial is testing

Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Boehringer Ingelheim 178
Large-scale testing (Phase 3)Study completedNCT00131144
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 583
Testing effectiveness (Phase 2)Ended earlyNCT05038020
What this trial is testing

Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)

Who this might be right for
Diabetic Retinopathy
Alkahest, Inc. 3
Testing effectiveness (Phase 2)Ended earlyNCT00211471
What this trial is testing

Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).

Who this might be right for
Severe Diabetic RetinopathyCentral Retinal Vein OcclusionChronic Inflammation+1 more
Manhattan Eye, Ear & Throat Hospital
Large-scale testing (Phase 3)Study completedNCT00130845
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 312
Early research (Phase 1)UnknownNCT05695417
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy
Ocular Therapeutix, Inc. 21
Testing effectiveness (Phase 2)Study completedNCT01805297
What this trial is testing

Aflibercept Injection for Proliferative Diabetic Retinopathy

Who this might be right for
Vitreous Hemorrhage
University of Oklahoma 12
Large-scale testing (Phase 3)Ended earlyNCT00248157
What this trial is testing

Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 105
Not applicableUnknownNCT02671864
What this trial is testing

Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy

Who this might be right for
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris 7,200
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation